EQS-Adhoc: Achiko's Commercialisation Update: Optimised second-generation Covid-19 diagnostic test receives full product registration approval in Indonesia
|
EQS-Ad-hoc: Achiko AG / Key word(s): Miscellaneous Achiko's Commercialisation Update: Optimised second-generation Covid-19 diagnostic test receives full product registration approval in Indonesia 08-Dec-2021 / 06:45 CET/CEST Release of an ad hoc announcement... |